XLO Insider Holders & Insider Ownership

List of insiders holdings for Xilio Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
GILEAD SCIENCES INC. 10% Owner	2024-04-05 16:31:53	7,345,473 0	7,345,473	Form 13G
SV7 Impact Medicine Fund LP SV7 (IMF) GP LLP 10% Owner	2021-11-03 16:20:18	1,613,632 1,613,632	3,227,264	Form 4/A
Rock Springs Capital Management LP Rock Springs Capital LLC Rock Springs Capital Master Fund LP Four Pines Master Fund LP 10% Owner	2024-04-05 14:51:59	3,003,259 0	3,003,259	Form 13G
Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner	2024-02-09 16:33:08	2,019,563 734,546	2,754,109	Form 4
FMR LLC See Remark 1	2023-02-09 08:14:52	1,907,671 0	1,907,671	Form 13G
TAKEDA PHARMACEUTICAL CO LTD Takeda Ventures Inc. 10% Owner	2022-01-14 06:07:32	1,475,121 0	1,475,121	Form 13G
RiverVest Venture Fund IV L.P. 10% Owner	2021-11-05 12:54:02	1,441,444 0	1,441,444	Form 13D
Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund II L.P. Bain Capital Life Sciences Investors II LLC BCLS II Investco LP BCLS II Investo (GP) LLC BCIP Life Sciences Associates LP 10% Owner	2022-02-14 06:42:51	1,348,682 0	1,348,682	Form 13G
BAY CITY CAPITAL LLC 10% Owner	2021-10-26 17:02:14	0 1,129,490	1,129,490	Form 4
Merck KGaA 10% Owner	2021-10-26 17:06:33	0 680,825	680,825	Form 4
Russo Rene PRESIDENT AND CEO	2024-05-03 16:10:14	474,000 0	474,000	Form 4
LYNCH DANIEL Director 10% Owner	2021-10-21 20:39:43	335,394 0	335,394	Form 3
FIL Ltd See Remark 1	2021-10-28 15:57:55	0 218,705	218,705	Form 4
Frankenfield Christopher James CHIEF OPERATING OFFICER	2024-05-03 16:10:19	208,000 0	208,000	Form 4
Alexandria Venture Investments LLC 10% Owner	2021-10-26 16:51:39	166,423 0	166,423	Form 4
Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D	2023-08-18 20:30:10	136,500 0	136,500	Form 4
TOMLINSON SIMON M 10% Owner	2021-10-21 20:52:00	131,117 0	131,117	Form 3
CLACKSON TIMOTHY P 10% Owner	2021-10-21 20:52:26	40,863 70,888	111,751	Form 3
Williams John Charles 10% Owner	2021-10-22 20:16:11	100,080 0	100,080	Form 3
Estate of Ulrich Rodeck 10% Owner	2021-10-21 20:53:12	100,080 0	100,080	Form 3
Luptakova Katarina CHIEF MEDICAL OFFICER	2024-05-03 16:10:27	59,333 0	59,333	Form 4
HUMPHREY RACHEL Director	2021-10-21 20:41:15	58,133 0	58,133	Form 3
Giovine Salvatore CHIEF FINANCIAL OFFICER	2022-02-24 17:30:34	49,500 0	49,500	Form 4
English Edward C PRINCIPAL ACCOUNTING OFFICER	2023-01-04 16:09:06	24,000 0	24,000	Form 4
Brennan Kevin M. SVP, FINANCE AND ACCOUNTING	2024-05-03 16:10:20	20,000 0	20,000	Form 4
Clancy Paul J Director	2023-06-13 16:30:22	13,200 0	13,200	Form 4
Rossi Christina Director	2023-06-13 16:30:26	13,200 0	13,200	Form 4
Bonstein Sara Director	2023-06-13 16:30:32	13,200 0	13,200	Form 4
Xu Yuan Director	2023-06-13 16:30:32	13,200 0	13,200	Form 4
Heyman Tomas J. Director	2023-06-13 16:30:35	13,200 0	13,200	Form 4
ROSS ROBERT W. Director	2023-06-13 16:30:43	13,200 0	13,200	Form 4
Ross Michael Jay Director	2022-06-17 16:30:50	13,200 0	13,200	Form 4
Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Possible Member of 10% Group 10% Owner	2022-12-29 17:24:09	0 0	0	Form 13G
Curran Daniel J. Director	2021-10-21 20:46:33	0 0	0	Form 3

Insider Holders & Insider Ownership - Xilio Therapeutics Inc. (XLO)